Echocardiographic Evidence for Increased Cardiac Performance During Early Renal Hypertension in Dogs

Cardiac function early (less than 4 weeks) in the course of experimental renal hypertension was investigated. In 11 male mongrel dogs, one kidney was wrapped in silk to produce two-kidney, one-wrapped hypertension. Two weeks later, the contralateral kidney was removed. Five sham-wrapped and then contralaterally-nephrectomized dogs served as controls. M-mode left ventricular (LV) echocardiograms were recorded twice weekly in all dogs for 4 weeks before and for 2 weeks after wrapping (or sham-wrapping) and for 4 weeks after nephrectomy. In the 11 hypertensive dogs, mean arterial pressure (MAP) rose from 127 mm Hg (mean) to 143 two weeks after wrapping (p<0.05) and to 185 two weeks after nephrectomy (p<0.001). The fractional shortening of the left ventricle (%D) of hypertensive dogs was increased (9% maximum, mean, p<0.01) for 2 weeks after wrapping and for one week after nephrectomy. Two weeks after wrapping, LV end-systolic wall stress calculated from femoral artery peak systolic pressure, end-systolic dimension and wall thickness was unchanged, suggesting that increased myocardial contractility accounted for the findings. In normotensive control dogs, there were no echocardiographic changes during the study.     

Chronobiologically Explored Effects of Telmisartan

Effects of Micardis (Telmisartan), alone or with low-dose aspirin, on blood pressure and other cardiovascular endpoints are examined in 20 patients with MESOR-hypertension in a crossover, double-blind, randomized study consisting of three stages, each lasting 7 days: I-placebo, II-Micardis, and III-Micardis with low-dose aspirin. Treatment was administered each day at a different circadian stage, upon awakening, and 3, 6, 9, 12, 15 and 18 hr after awakening. During each stage, the following variables were measured at 3-hr intervals during waking: systolic and diastolic blood pressure, heart rate, ejection fraction, intrarenal resistive index, acceleration time, and serum creatinine. Each data series was analyzed by single cosinor. Results were summarized by population-mean least squares spectra. At matched treatment times, the MESOR and circadian amplitude of each variable were compared among the three treatments by paired t-tests. A prominent circadian rhythm characterizes all variables. Micardis was associated not only with a lowering of blood pressure, but also with a reduction of the circadian blood pressure amplitude. The ejection fraction was increased, and the resistive index and acceleration time were decreased, the effect being more pronounced when low-dose aspirin was added to Micardis. Any circadian-stage dependent effect of Micardis, with or without low-dose aspirin, will require monitoring over spans longer than a single day for a given treatment administration time.     

Is anterior decompression and fusion superior to laminoplasty for cervical myelopathy due to ossification of posterior longitudinal ligament? A systematic review and meta-analysis

Context: Considerable controversy exists over surgical procedures for ossification of the posterior longitudinal ligament (OPLL).Objective: The purpose of the meta-analysis was to compare the clinical outcome of anterior decompression and fusion (ADF) with laminoplasty (LAMP) in treatment of cervical myelopathy due to OPLL.Methods: PubMed, EMBASE and the Cochrane Register of Controlled Trials database were searched to identify potential clinical studies compared ADF with LAMP for cervical myelopathy owing to OPLL. We also manually searched the reference lists of articles and reviews for possible relevant studies. Thirteen studies with 1120 patients were included in our analysis. Subgroup analyses were performed by the canal occupying ratio of OPLL.Results: Overall, the mean preoperative Japanese Orthopaedic Association (JOA) score was similar between two groups. Compared with LAMP group, ADF group was higher at the mean postoperative JOA scores and mean recovery rate, reoperation rate, and longer at mean operation time. There was not significantly different in mean blood loss and complication rate between two groups. In subgroup analysis, ADF had a higher mean postoperative JOA score and recovery rate than LAMP in cases of OPLL with occupying ratios ≥ 50%, while those difference were not found in cases of OPLL with occupying ratios < 50%.Conclusion: ADF achieves better neurological improvement compared with LAMP in treatment of cervical myelopathy due to OPLL, especially in cases of OPLL with occupying ratios ≥ 50%. Complication rate is similar between two groups, but ADF can increase the risk of reoperation     

Skin permeation and metabolism of di(2-ethylhexyl) phthalate (DEHP)

Phthalates are suspected to be endocrine disruptors. Di(2-ethylhexyl) phthalate (DEHP) is assumed to have low dermal absorption; however, previous in vitro skin permeation studies have shown large permeation differences. Our aims were to determine DEHP permeation parameters and assess extent of skin DEHP metabolism among workers highly exposed to these lipophilic, low volatile substances.     

人血丙种球蛋白治疗重症手足口病48例

目的:探讨人血丙种球蛋白对重症手足口病(神经系统受累期)早期治疗的临床体会,为重症手足口病的临床治疗提供参考。方法:回顾性总结分析我院在2012年8月至2013年9月期间收治的96例重症手足口病患者的临床病例资料,随机分为治疗组和对照组各48例,两组均用利巴韦林、甲基泼尼松龙和甘露醇治疗,治疗组加人血丙种球蛋白进行治疗,比较两组患者的临床治疗效果及死亡率。结果:治疗组和对照组临床疗效及死亡率差异有显著统计学意义(P0.01)。结论:早期应用人血丙种球蛋白治疗重症手足口病疗效好,住院天数缩短,死亡率明显下降。     

Advances in Percutaneous Coronary Interventions for Elderly Patients

Coronary heart disease (CHD) is one of the leading causes of morbidity and the most common cause of death in older adults. Paradoxically, elderly patients tend to be systematically excluded from randomized-controlled cardiovascular trials, which complicates decision-making in this population. Management of CHD in the elderly is frequently more difficult in virtue of chronic comorbid conditions and aging-intrinsic dynamics. Despite these challenges, the number of elderly and very elderly patients undergoing percutaneous coronary interventions (PCI) is increasing. Elderly patients in many registries and large clinical series exhibit even a greater benefit from interventional procedures than younger patients, but they have a higher rate of overall complications. We present an overview of the current available evidence of PCI in older adults with stable and unstable CHD, including comparisons between drug-eluting and bare-metal stents, transfemoral and transradial access, and methods of revascularization. Adjuvant antiplatelet and antithrombotic therapies are also discussed.